Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease

NCT01227681 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Difficulty in Recruitment

Conditions

Parkinson Disease

Interventions

DRUG: G-CSF
DRUG: Placebo

Sponsor

Buddhist Tzu Chi General Hospital